These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 1628144

  • 1. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
    Männistö PT, Tuomainen P, Tuominen RK.
    Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
    Törnwall M, Kaakkola S, Tuomainen P, Kask A, Männistö PT.
    Br J Pharmacol; 1994 May; 112(1):13-8. PubMed ID: 7518301
    [Abstract] [Full Text] [Related]

  • 3. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT, Tuomainen P.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [Abstract] [Full Text] [Related]

  • 4. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
    Kaakkola S, Wurtman RJ.
    J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
    [Abstract] [Full Text] [Related]

  • 5. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
    Törnwall M, Tuomainen P, Männistö PT.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):39-45. PubMed ID: 8223912
    [Abstract] [Full Text] [Related]

  • 6. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
    Napolitano A, Bellini G, Borroni E, Zürcher G, Bonuccelli U.
    Parkinsonism Relat Disord; 2003 Jan 03; 9(3):145-50. PubMed ID: 12573869
    [Abstract] [Full Text] [Related]

  • 7. CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure.
    Waldmeier PC, Baumann PA, Feldtrauer JJ, Hauser K, Bittiger H, Bischoff S, von Sprecher G.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep 03; 342(3):305-11. PubMed ID: 1980718
    [Abstract] [Full Text] [Related]

  • 8. The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
    Gerlach M, Xiao AY, Kuhn W, Lehnfeld R, Waldmeier P, Sontag KH, Riederer P.
    J Neural Transm (Vienna); 2001 Sep 03; 108(2):189-204. PubMed ID: 11314772
    [Abstract] [Full Text] [Related]

  • 9. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
    Brannan T, Martínez-Tica J, Yahr MD.
    Neurology; 1992 Mar 03; 42(3 Pt 1):683-5. PubMed ID: 1549240
    [Abstract] [Full Text] [Related]

  • 10. Effects of CGP 28014 on the in vivo release and metabolism of dopamine in the rat striatum assessed by brain microdialysis.
    Steulet AF, Stöcklin K, Wicki P, Waldmeier P.
    Neurochem Res; 1993 Nov 03; 18(11):1131-6. PubMed ID: 8255364
    [Abstract] [Full Text] [Related]

  • 11. Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.
    Törnwall M, Männistö PT.
    Eur J Pharmacol; 1993 Nov 30; 250(1):77-84. PubMed ID: 8119326
    [Abstract] [Full Text] [Related]

  • 12. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T, Prikhojan A, Yahr MD.
    J Neural Transm (Vienna); 1997 Nov 30; 104(1):77-87. PubMed ID: 9085195
    [Abstract] [Full Text] [Related]

  • 13. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Kaakkola S, Wurtman RJ.
    Brain Res; 1992 Aug 07; 587(2):241-9. PubMed ID: 1381981
    [Abstract] [Full Text] [Related]

  • 14. Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats.
    Männistö PT, Tuomainen P, Toivonen M, Törnwall M, Kaakkola S.
    J Neural Transm Park Dis Dement Sect; 1990 Aug 07; 2(1):31-43. PubMed ID: 2113389
    [Abstract] [Full Text] [Related]

  • 15. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M, Passlin M, Nordberg HL, Forsberg M, Kotisaari S, Tuomisto L, Shintani F, Tanaka KF, Reenilä I, Laitinen K, Männistö PT.
    J Neurosci Methods; 2001 Aug 15; 109(1):47-52. PubMed ID: 11489299
    [Abstract] [Full Text] [Related]

  • 16. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
    Napolitano A, Zürcher G, Da Prada M.
    Eur J Pharmacol; 1995 Feb 06; 273(3):215-21. PubMed ID: 7737328
    [Abstract] [Full Text] [Related]

  • 17. Catechol O-methyltransferase: characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors.
    Männistö PT.
    Adv Pharmacol; 1998 Feb 06; 42():324-8. PubMed ID: 9327906
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.
    Nissinen E, Lindén IB, Schultz E, Pohto P.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep 06; 346(3):262-6. PubMed ID: 1407012
    [Abstract] [Full Text] [Related]

  • 19. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.
    Acquas E, Carboni E, de Ree RH, Da Prada M, Di Chiara G.
    J Neurochem; 1992 Jul 06; 59(1):326-30. PubMed ID: 1613509
    [Abstract] [Full Text] [Related]

  • 20. Neurochemical and psychomotor interactions of new selective COMT inhibitors with clorgyline and nomifensine in levodopa-treated rats and mice.
    Törnwall M, Tuomainen P, Männistö PT.
    Arch Int Pharmacodyn Ther; 1992 Jul 06; 320():5-20. PubMed ID: 1300941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.